July 3 (Reuters) - AstraZeneca (AZN.L), opens new tab is in talks with Summit Therapeutics (SMMT.O), opens new tab to license an experimental lung-cancer drug under a deal worth as much as $15 billion ...
Monday - Friday, 6:00 - 7:00 PM ET In a Tuesday interview with CNBC's Jim Cramer, AstraZeneca CEO Pascal Soriot explained why the drugmaker believes it can almost double revenue by the end of the ...
The U.K. pharmaceutical company AstraZeneca has become the largest multinational drugmaker in China, drawing 13% of its $5.8 billion in revenue last year from there, against a backdrop of an acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results